BOT 3.73% 32.3¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-240

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,209 Posts.
    lightbulb Created with Sketch. 5511
    Correction for you.

    PE on ASX is based on profit, not gross sales EBOTI. So where you say 750 per unit... that is a gross sales price, and need to take all costs out of that first, then apply tax, then use the new figure ( I was using $200 ). And back convert to aud.

    However, agree I think SP will be somewhere in the single digits by next year. I hope the company release the sales data so we can more or less compare success against Kaken.


    Well done to everyone who held over that decision. It took some intestinal fortitude for sure, but in 5 years time I bet everyone will be looking at BOT graph saying, I wish I was able to purchase pre FDA approval!!

    Now it's over to the team to smash sales out of the park. Keep an eye on the influencer scene to see how BOT fares in the marketing next quarter!

    Get it Vince!!!!!




 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.3¢
Change
-0.013(3.73%)
Mkt cap ! $586.1M
Open High Low Value Volume
33.5¢ 33.8¢ 31.5¢ $1.565M 4.806M

Buyers (Bids)

No. Vol. Price($)
19 547903 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 40922 19
View Market Depth
Last trade - 14.12pm 12/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.